Société de Therapeutique Marocaine S.A. (CBSE:SOT)

CBSE:SOT Balance Sheet

Financials in millions MAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	150.25	148.85	77.18	47.8	44.93	88.16
Short-Term Investments	-	-	-	5.6	4.61	-
Cash & Short-Term Investments	150.25	148.85	77.18	53.39	49.55	88.16
Cash Growth	2.04%	92.86%	44.55%	7.76%	-43.80%	242.81%
Accounts Receivable	1,312	960.7	868.66	789.5	676.62	549.55
Other Receivables	3.46	240.9	280.62	139.96	84.39	65.75
Receivables	1,316	1,202	1,149	929.45	761.01	615.3
Inventory	1,317	1,069	919.54	807.99	705.02	578.13
Other Current Assets	21.08	53.5	38.42	20.46	9.09	14.15
Total Current Assets	2,804	2,473	2,184	1,811	1,525	1,296
Property, Plant & Equipment	1,040	1,038	894.49	824.58	839.47	741.26
Long-Term Investments	0.28	2.43	1.56	2.1	3.28	-
Goodwill	1,002	1,006	30.76	38.16	38.16	38.16
Other Intangible Assets	111.64	40.01	26.42	20.06	19.77	23.72
Long-Term Deferred Tax Assets	0.61	0.91	1.01	2.53	3.93	2.7
Long-Term Deferred Charges	-	-	-	4.35	1.67	-
Other Long-Term Assets	69.46	47.07	43.39	46.81	40.56	24.35
Total Assets	5,029	4,607	3,182	2,750	2,472	2,126

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1,307	562.01	519.05	469.8	392.33	316.33
Accrued Expenses	-	133.46	119.11	56.51	81.58	64.53
Short-Term Debt	-	271.02	224.11	219.26	212.39	167.9
Current Portion of Long-Term Debt	545.6	310.29	208.44	152.74	47.09	43.84
Current Income Taxes Payable	21.29	63.86	8.95	5.33	10.25	20.94
Current Unearned Revenue	-	7.93	3.6	0.26	12.67	7.84
Other Current Liabilities	18.83	58.36	92.33	63.58	50.71	85.23
Total Current Liabilities	1,893	1,407	1,176	967.48	807.03	706.61
Long-Term Debt	289.35	395.41	156.06	129.82	92.45	11.94
Pension & Post-Retirement Benefits	-	35.85	30.42	22.53	25.01	26.33
Long-Term Deferred Tax Liabilities	102.39	109.67	102.87	106.25	107.9	79.44
Other Long-Term Liabilities	50.95	9.72	9.8	5.29	5.44	11.86
Total Liabilities	2,335	1,958	1,475	1,231	1,038	836.17

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	383.1	380.34	360	360	360	360
Additional Paid-In Capital	687.33	610.09	-	-	-	-
Retained Earnings	215.07	385.53	315.29	262.76	266.62	278.85
Comprehensive Income & Other	1,376	1,244	1,009	876.8	788.71	655.68
Total Common Equity	2,662	2,620	1,684	1,500	1,415	1,295
Minority Interest	31.55	30.03	23.14	18.95	18.35	-4.77
Shareholders' Equity	2,694	2,650	1,707	1,519	1,434	1,290
Total Liabilities & Equity	5,029	4,607	3,182	2,750	2,472	2,126

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	834.96	976.72	588.61	501.82	351.93	223.68
Net Cash (Debt)	-684.7	-827.87	-511.43	-448.43	-302.38	-135.52
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-12.77	-21.77	-14.21	-12.46	-8.40	-3.76
Filing Date Shares Outstanding	38.31	38.03	36	36	36	36
Total Common Shares Outstanding	38.31	38.03	36	36	36	36
Working Capital	911.92	1,066	1,009	843.82	717.64	589.14
Book Value Per Share	69.49	68.88	46.78	41.65	39.31	35.96
Tangible Book Value	1,548	1,574	1,627	1,441	1,357	1,233
Tangible Book Value Per Share	40.41	41.39	45.19	40.04	37.71	34.24
Land	-	325.39	280.47	288.14	285.51	211.8
Buildings	-	642.32	545	511.79	494.52	483.96
Machinery	-	526.07	442.58	424.74	485.8	469.36
Construction In Progress	-	114.12	135.75	134.91	90.7	52.2

Data Source: S&P Global Market Intelligence Last updated: May 2, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 6, 2026

Data Sources Report a data error